The primary focus is on the company’s bexotegrast, an αvß6/αvß1 integrin inhibitor, which is being developed for the treatment of idiopathic pulmonary fibrosis (IPF). The enrollment for the Phase 2b/3 ...

NuvoAir Medical, a national leader in cardiopulmonary services will open an outpatient pulmonary clinic in Prescott, in order to keep outpatient pulmonary care local to Prescott-area residents.

Shares of Veracyte, Inc. (NASDAQ:VCYT – Get Free Report) gapped up before the market opened on Thursday following a better than expected earnings announcement. The stock had previously closed at ...

These compelling results support advancing the development of nintedanib DPI for patients living with IPF, a chronic and progressive fibrotic lung disease with limited treatment options,” said Michael ...

Walker announced earlier in the month that he was retiring from radio after 58 years due to ill health, having been previously diagnosed with idiopathic pulmonary fibrosis (IPF). After playing Johnny ...

Nashville, Tennessee Friday, November 8, 2024, 13:00 Hrs [IST] ...

and idiopathic pulmonary fibrosis (IPF). Receive News & Ratings for Syndax Pharmaceuticals Daily - Enter your email address ...

Interested parties may access the live audio webcast for each conference via the Investors section of the Surrozen website at https://investors.surrozen.com/events-presentations/events-calendar. A ...

Lung transplantation stands as a critical option for patients suffering from end-stage diseases such as chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis, and cystic fibrosis ...

Good day, everyone, and welcome to the Syndax Third Quarter 2024 Earnings Conference Call. Today's call is being recorded. All participants have been placed in a listen-only mode. You'll have an ...